Does bevacizumab improve survival in patients with metastatic colorectal cancer treated with chemotherapy?

Axel F Grothey

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)22-23
Number of pages2
JournalNature Clinical Practice Oncology
Volume3
Issue number1
DOIs
StatePublished - Jan 2006

Fingerprint

Leucovorin
Fluorouracil
Colorectal Neoplasms
Drug Therapy
Survival
Bevacizumab

Keywords

  • Bevacizumab
  • Colorectal cancer
  • Fluorouracil
  • Leucovorin
  • Survival

ASJC Scopus subject areas

  • Oncology

Cite this

Does bevacizumab improve survival in patients with metastatic colorectal cancer treated with chemotherapy? / Grothey, Axel F.

In: Nature Clinical Practice Oncology, Vol. 3, No. 1, 01.2006, p. 22-23.

Research output: Contribution to journalArticle

@article{998037c885454aa4bf9b2e92423c5aaf,
title = "Does bevacizumab improve survival in patients with metastatic colorectal cancer treated with chemotherapy?",
keywords = "Bevacizumab, Colorectal cancer, Fluorouracil, Leucovorin, Survival",
author = "Grothey, {Axel F}",
year = "2006",
month = "1",
doi = "10.1038/ncponc0380",
language = "English (US)",
volume = "3",
pages = "22--23",
journal = "Nature Reviews Clinical Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Does bevacizumab improve survival in patients with metastatic colorectal cancer treated with chemotherapy?

AU - Grothey, Axel F

PY - 2006/1

Y1 - 2006/1

KW - Bevacizumab

KW - Colorectal cancer

KW - Fluorouracil

KW - Leucovorin

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=30944458460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30944458460&partnerID=8YFLogxK

U2 - 10.1038/ncponc0380

DO - 10.1038/ncponc0380

M3 - Article

C2 - 16407876

AN - SCOPUS:30944458460

VL - 3

SP - 22

EP - 23

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

SN - 1759-4774

IS - 1

ER -